Associate Professor Steven Tong is an infectious diseases physician with the Victorian Infectious Diseases Service and Co-Head of the Translational and Clinical Research and Indigenous Health cross-cutting disciplines at the Doherty Institute. He spent 10 years in Darwin before moving Melbourne to join the Doherty Institute in 2016. His research interests include skin pathogens (Staphylococcus aureus, Group A Streptococcus), hospital infections, Indigenous health, viral hepatitis and influenza. He leads clinical trials for Staphylococcus aureus bloodstream infections.
Updates On The Management Of Staphylococcus Aureus And Streptococcus Pyogenes Infections
This presentation will cover staphylococcal and streptococcal infections, including invasive infections and skin and soft tissue infections. There is an increasing incidence of invasive Staphylococcus aureus and Streptococcus pyogenes in Australia. The most recent Therapeutic Guidelines: Antibiotics incorporates changes in recommendations for the management of such infections: 1) the inclusion of cefazolin as recommended therapy for S. aureus bacteraemia; 2) consideration of antibiotic prophylaxis for close contacts of patients with S. pyogenes bacteraemia; 3) use of penicillin for streptococcal cellulitis. Recent clinical trials that open the door for early oral switch for staphylococcal endocarditis and bone and joint infections will be reviewed. Finally, some key clinical uncertainties in the management of S. aureus bacteraemia will be discussed and a potential way forward suggested to address these uncertainties.